We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Non-small Cell Lung Cancer and Quality of Life (SILKE)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00818402
First Posted: January 7, 2009
Last Update Posted: May 29, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Maria Silvoniemi, University of Turku
January 5, 2009
January 7, 2009
May 29, 2015
August 2008
February 2012   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00818402 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Non-small Cell Lung Cancer and Quality of Life
Treatment of Non-small Cell Lung Cancer -Effects on Quality of Life and Symptom Control
The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
whole blood
Non-Probability Sample
The patients treated in the clinic of respiratory medicine in Turku, Finland
Non Small Cell Lung Cancer
Not Provided
Non-small cell lung cancer patients
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
130
February 2012
February 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with verified NSCLC
  • after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
  • Finnish speaking patients
  • aged 18 years or more
  • Written informed consent has to be signed

Exclusion Criteria:

  • Patients not consenting to participate in the study
  • patients not able to communicate sufficiently
  • cancer type is other than non-small-cell lung cancer
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
Finland
 
NCT00818402
SILKE-ETMK:47/180/2008
No
Not Provided
Not Provided
Maria Silvoniemi, University of Turku
University of Turku
Not Provided
Not Provided
University of Turku
May 2015